Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

230.25 +1.46 (+0.64%)
Streaming Delayed Price Updated: 12:00 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 695,517
Open 229.46
Bid (Size) 230.20 (100)
Ask (Size) 230.29 (100)
Prev. Close 228.79
Today's Range 228.98 - 230.80
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 2.85%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Top 5 US Healthcare Stocks By Market Value ↗
Weight-loss drugs, drug-pricing reforms, and legal challenges have reshaped the U.S. healthcare landscape in 2025. 
Via Stocktwits
News headline image
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
As the biotech sector closes out a transformative 2025, one name has risen to the top of every institutional investor's watchlist: Abivax (NASDAQ: ABVX). Following a year of stellar clinical results... 
Via MarketMinute
Topics Intellectual Property

Performance

YTD
+28.3%
+28.3%
1 Month
+0.3%
+0.3%
3 Month
+3.4%
+3.4%
6 Month
+24.1%
+24.1%
1 Year
+29.1%
+29.1%

More News

Read More
News headline image
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Dividend Growth Stocks Analysts Are Upgrading for 2026 ↗
Via MarketBeat
News headline image
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗
Via Stocktwits
Topics Economy Government
News headline image
This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Want $10,000 in Passive Income? This Vanguard ETF Could Be Your Ticket to Making It Happen. ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Is AbbVie a Millionaire Maker? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market. ↗
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
The Yield Search: Why Retirees are Swapping Growth for Defense in a Shifting 2025 Market
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
Want Decades of Passive Income? Buy This ETF and Hold It Forever. ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗
Via Stocktwits
Topics Government World Trade
News headline image
My Top 3 Healthcare Stocks to Buy in 2026 ↗
Via The Motley Fool
News headline image
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul ↗
Via MarketBeat
News headline image
The Smartest Dividend Stocks to Buy With $5,000 Right Now ↗
Via The Motley Fool
Topics Retirement
News headline image
2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore
Via StockStory
News headline image
Is AbbVie Stock Too Cheap to Ignore at Today's Price? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Guardian Wealth Doubles Down on LKQ Stock With $1.8 Million Purchase, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Guardian Wealth Takes $5.1 Million Stake in Viper Energy, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
1 Major Factor Behind the Healthcare Sector's Recent Surge ↗
Via The Motley Fool
News headline image
3 Top Dividend Stocks to Buy in December ↗
Via The Motley Fool
Topics Initial Public Offering Intellectual Property
News headline image
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. ↗
Via The Motley Fool
Topics ETFs
News headline image
Could Buying AbbVie Today Set You Up for Life? ↗
Via The Motley Fool
Topics Intellectual Property Lawsuit

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 230.25
When was AbbVie last traded?
The last trade of AbbVie was at 12/24/25 12:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.